NIH screening to see which blood studies fit you
Part of Blood & lymphatic, Cancer clinical trials.
This study is a general screening step at the NIH Clinical Center to check whether you might qualify for other NHLBI research protocols. It helps match you (or a donor/healthy volunteer) to the right study and confirms you can consent to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are seeking screening because you may fit an NHLBI blood/stem cell/healthy-volunteer study
- Your screening is based on info from your outside doctor that suggests you might qualify
- You are at least 2 years old (and healthy volunteers must be at least 8 years old)
- You weigh more than 12 kg if you are a healthy volunteer
- You (or your guardian or legally authorized representative) can understand and sign the consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects blood, urine, and other samples from healthy volunteers to support medical research. Depending on the type of sample, you may donate blood, provide skin samples, or participate in other non-invasive procedures. Your samples help scientists understand health and develop new treatments.
This study collects information about standard care for people seen by the NHLBI, and also about donors. It helps researchers understand what happens in real-world care, which can improve future treatment decisions.
This study collects tissue samples from patients with cancer or blood disorders, and from their matching family members who might donate stem cells for transplant. The samples help researchers understand these diseases and develop better treatments.
This study collects blood from people already in an NIH (National Institutes of Health) clinical research program to run genetic tests. It may help researchers understand cancer and related inherited conditions by studying DNA changes.
This study screens people who may have an inherited immune system condition (like problems with immune cell growth or death) and their blood relatives. The goal is to understand the condition better by collecting blood samples for testing.
This study helps collect information and provide certain clinical care and interventions for people who come to the National Cancer Institute (NCI) Clinical Center (CCR). It may be a fit if you need NCI-level evaluation or support because your condition is complex, or if you’re involved as a cellular therapy donor or certain family members needing genetic testing.
Hear when a new Hematologic Disease and Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.